ArticleCureus2024
Hepatitis C-Induced Immunoglobulin A (IgA) Nephropathy: An Uncommon Cause of Hematuria.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An Unusual Presentation of IgA Vasculitis and IgA Nephropathy: A Case Report.Journal of community hospital internal medicine perspectives · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immunoglobulin (Ig)A nephropathy, also known as Berger's disease, is characterized by IgA deposits in the kidney's mesangium and can lead to serious outcomes, including rapidly progressive glomerulonephritis. While Hepatitis C virus (HCV) infection is commonly associated with liver involvement, it is also linked to various renal pathologies, including membranous nephropathy and membranoproliferative glomerulonephritis. However, IgA nephropathy secondary to HCV is rare. This case study involves a 24-year-old male with a known history of untreated Hepatitis C, who presented with hematuria and foamy urine. Laboratory findings revealed increased levels of serum creatinine and urea, significant proteinuria, and a high HCV RNA viral load. A renal biopsy confirmed the diagnosis of IgA nephropathy with strong IgA and C3 deposits observed on immunofluorescence. Treatment with angiotensin receptor blockers and antiviral therapy led to substantial symptomatic improvement and stabilization of renal function. This case underscores the critical importance of considering IgA nephropathy in the differential diagnosis of renal complications in HCV-infected patients. Early detection and treatment of Hepatitis C are vital, as timely intervention can markedly enhance patient outcomes and mitigate the risk of serious complications. A heightened awareness of the potential renal implications of HCV emphasizes the urgency of proactive monitoring and swift management to safeguard kidney function and overall health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.